Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05207943 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of the NXSignal Device for the Treatment of Anterior Cruciate Ligament Injuries

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 28, 2025 (before its estimated September 25, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Site contact updated
    • Publications: details revised at 4 of 4 entries
    v11
  2. Primary completion date: Sep 25, 2024 to Sep 25, 2025
    • Site contact updated
    • Publications: details revised at 4 of 4 entries
    v10
  3. Primary completion date: Apr 25, 2024 to Sep 25, 2024v9
  4. Primary completion date: Dec 25, 2023 to Apr 25, 2024
    • Study completion date: Apr 25, 2024 to Dec 25, 2025
    v8
  5. Primary completion date: Sep 25, 2023 to Dec 25, 2023
    • Study completion date: Jan 25, 2024 to Apr 25, 2024
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Primary completion date: Jun 25, 2023 to Sep 25, 2023
    • Study completion date: Oct 25, 2023 to Jan 25, 2024
    v6
  2. Primary completion date: Mar 25, 2023 to Jun 25, 2023
    • Study completion date: Jul 25, 2023 to Oct 25, 2023
    v5
  3. Primary completion date: Nov 25, 2022 to Mar 25, 2023
    • Study completion date: Feb 25, 2023 to Jul 25, 2023
    v4
  4. Primary completion date: Jul 25, 2022 to Nov 25, 2022
    • Study completion date: Dec 25, 2022 to Feb 25, 2023
    v3
  5. Primary completion date: Mar 25, 2022 to Jul 25, 2022
    • Study completion date: Jun 25, 2022 to Dec 25, 2022
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Injury to the anterior cruciate ligament (ACL) is very common among sports professionals and the general population \[. Unlike other joint injuries, it is reversible, but it can damage adjacent tissues, particularly the meniscus, and catalyze knee osteoarthritis. ACL injury produces instability, joint mechanical alteration, which can lead to degenerative joint diseases. The goal of treating the injury will be to prevent symptomatic instability, restore normal knee kinematics, and prevent degenerative joint disease . Its usual treatment is surgical and therefore contributes to a significant cost for the health system, both for the surgeries themselves, and for the rehabilitation and subsequent recovery processes. Within recovery therapies, in some cases, and given their popularity within the world of physiotherapy, electrotherapy techniques are proposed, primarily transcutaneous electrical nerve stimulation-type techniques with action on the muscular system and analgesia. An early intervention with neuromuscular electrostimulation electrotherapy (NMES) combined with repeated exercises is effective for the recovery of strength and restoration of the biomechanical symmetry of the limb. There is a diversity of opinions and disparate results regarding the use of this type of technique , in any case, it has been shown that electrical stimulation favors cell migration and joint tissue regeneration.
Trial Details
NCT Number NCT05207943
Lead Sponsor University of Las Palmas de Gran Canaria
Conditions
(from sponsor)		 Anterior Cruciate Ligament Injuries
Related terms Anterior Cruciate Ligament Injuries
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov